Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission
Goldhirsch A et al. (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol16: 1569–1583 ArticleCASPubMed Google Scholar
Eifel P et al. (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst93: 979–989 ArticleCASPubMed Google Scholar
Early Breast Cancer Trialists' Collaborative Group (1988). Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med319: 1681–1692
Lipshutz RJ et al. (1995) Using oligonucleotide probe arrays to access genetic diversity. Biotechniques19: 442–447 CASPubMed Google Scholar
Schena M et al. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science270: 467–470 ArticleCASPubMed Google Scholar
Quackenbush J (2006) Microarray analysis and tumor classification. N Engl J Med354: 2463–2472 ArticleCASPubMed Google Scholar
Reis-Filho JS et al. (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol59: 225–231 ArticleCASPubMedPubMed Central Google Scholar
Brenton JD et al. (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol23: 7350–7360 ArticleCASPubMed Google Scholar
Sorlie T (2007) Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol360: 91–114 PubMed Google Scholar
Murad TM (1971) A proposed histochemical and electron microscopic classification of human breast cancer according to cell of origin. Cancer27: 288–299 ArticleCASPubMed Google Scholar
Hamperl H (1970) The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol53: 161–220 ArticleCASPubMed Google Scholar
Fadare O and Tavassoli FA (2007) The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv Anat Pathol14: 358–373 ArticleCASPubMed Google Scholar
Sorlie T et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA98: 10869–10874 ArticleCASPubMedPubMed Central Google Scholar
Sorlie T et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA100: 8418–8423 ArticleCASPubMedPubMed Central Google Scholar
Calza S et al. (2006) Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res8: R34 ArticleCASPubMedPubMed Central Google Scholar
Sotiriou C et al. (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA100: 10393–10398 ArticleCASPubMedPubMed Central Google Scholar
Perreard L et al. (2006) Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res8: R23 ArticleCASPubMedPubMed Central Google Scholar
Fan C et al. (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med355: 560–569 ArticleCASPubMed Google Scholar
van 't Veer LJ et al. (2003) Expression profiling predicts outcome in breast cancer. Breast Cancer Res5: 57–58 ArticlePubMed Google Scholar
van de Vijver MJ et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med347: 1999–2009 ArticleCASPubMed Google Scholar
van 't Veer LJ et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature415: 530–536 ArticleCASPubMed Google Scholar
Chang HY et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA102: 3738–3743 ArticleCASPubMedPubMed Central Google Scholar
Paik S et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med351: 2817–2826 ArticleCASPubMed Google Scholar
Paik S et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol24: 3726–3734 ArticleCASPubMed Google Scholar
Weigelt B et al. (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res65: 9155–9158 ArticleCASPubMed Google Scholar
Lacroix M et al. (2004) Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr Relat Cancer11: 497–522 ArticleCASPubMed Google Scholar
Li H et al. (2007) Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res67: 501–510 ArticleCASPubMed Google Scholar
Jumppanen M et al. (2007) Basal-like phenotype is not associated with patient survival in estrogen receptor negative breast cancers. Breast Cancer Res9: R16 ArticleCASPubMedPubMed Central Google Scholar
Ribeiro-Silva A et al. (2005) p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology47: 458–466 ArticleCASPubMed Google Scholar
Jacquemier J et al. (2005) Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol207: 260–268 ArticleCASPubMed Google Scholar
Kesse-Adu R and Shousha S (2004) Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma. Mod Pathol17: 646–652 ArticleCASPubMed Google Scholar
Rodriguez-Pinilla SM et al. (2007) Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol20: 474–481 ArticleCASPubMed Google Scholar
Harris LN et al. (2007) Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res13: 1198–1207 ArticleCASPubMed Google Scholar
Garcia S et al. (2007) Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol38: 830–841 ArticleCASPubMed Google Scholar
Foulkes WD et al. (2004) The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res64: 830–835 ArticleCASPubMed Google Scholar
Hannemann J et al. (2006) Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy. Br J Cancer95: 1334–1341 ArticleCASPubMedPubMed Central Google Scholar
Jones C et al. (2004) Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res10: 5988–5997 ArticleCASPubMed Google Scholar
Foulkes WD et al. (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst95: 1482–1485 ArticleCASPubMed Google Scholar
van der Groep P et al. (2004) Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst96: 712–713 ArticlePubMed Google Scholar
Palacios J et al. (2004) Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst96: 712–714 ArticlePubMed Google Scholar
Siziopikou KP and Cobleigh M (2007) The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast16: 104–107 ArticlePubMed Google Scholar
Rakha EA et al. (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol208: 495–506 ArticleCASPubMed Google Scholar
Livasy CA et al. (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol19: 264–271 ArticleCASPubMed Google Scholar
Nielsen TO et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res10: 5367–5374 ArticleCASPubMed Google Scholar
Kim MJ et al. (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol37: 1217–1226 ArticleCASPubMed Google Scholar
Kusinska R et al. (2005) Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2. Pol J Pathol56: 107–110 CASPubMed Google Scholar
Rodriguez-Pinilla SM et al. (2007) Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol60: 1006–1012 ArticlePubMed Google Scholar
Rodriguez-Pinilla SM et al. (2006) Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res12: 1533–1539 ArticleCASPubMed Google Scholar
Ribeiro-Silva A et al. (2006) Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. Am J Clin Pathol125: 512–518 ArticleCASPubMed Google Scholar
van de Rijn M et al. (2002) Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol161: 1991–1996 ArticleCASPubMedPubMed Central Google Scholar
Abd El-Rehim DM et al. (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol203: 661–671 ArticlePubMed Google Scholar
Kesse-Adu R and Shousha S (2004) Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma. Mod Pathol17: 646–652 ArticleCASPubMed Google Scholar
Hicks DG et al. (2006) Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol30: 1097–1104 ArticlePubMed Google Scholar
Potemski P et al. (2005) Prognostic relevance of basal cytokeratin expression in operable breast cancer. Oncology69: 478–485 ArticleCASPubMed Google Scholar
Charafe-Jauffret E et al. (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene25: 2273–2284 ArticleCASPubMed Google Scholar
Rouzier R et al. (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res11: 5678–5685 ArticleCASPubMed Google Scholar
Lakhani SR et al. (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res11: 5175–5180 ArticleCASPubMed Google Scholar
Laakso M et al. (2005) Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol18: 1321–1328 ArticleCASPubMed Google Scholar
Abd El-Rehim DM et al. (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol203: 661–671 ArticlePubMed Google Scholar
Reis-Filho JS et al. (2006) Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol19: 307–319 ArticleCASPubMed Google Scholar
Rodriguez Pinilla SM et al. (2006) Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat99: 85–90 ArticleCAS Google Scholar
Arnes JB et al. (2005) Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res11: 4003–4011 ArticleCASPubMed Google Scholar
Fulford LG et al. (2006) Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology49: 22–34 ArticleCASPubMed Google Scholar
Matos I et al. (2005) p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch447: 688–694 ArticleCASPubMed Google Scholar
Rakha EA et al. (2007) Prognostic markers in triple-negative breast cancer. Cancer109: 25–32 ArticleCASPubMed Google Scholar
Rakha EA et al. (2006) Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer42: 3149–3156 ArticleCASPubMed Google Scholar
Carey LA et al. (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA295: 2492–2502 ArticleCASPubMed Google Scholar
Collett K et al. (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev14: 1108–1112 ArticleCASPubMed Google Scholar
Paredes J et al. (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res11: 5869–5877 ArticleCASPubMed Google Scholar
Savage K et al. (2007) Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res13: 90–101 ArticleCASPubMed Google Scholar
Reis-Filho JS et al. (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology49: 10–21 ArticleCASPubMed Google Scholar
Fulford LG et al. (2007) Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res9: R4 ArticleCASPubMedPubMed Central Google Scholar
Yang XR et al. (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev16: 439–443 ArticleCASPubMed Google Scholar
Rakha EA et al. (2007) Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology50: 434–438 ArticleCASPubMed Google Scholar
Galaburda LS et al. (2007) Are the different molecularly-defined subtypes of invasive breast cancer associated with different reproductive risk factors? [abstract] Mod Pathol20 (Suppl 2): 31A Google Scholar
Fadare O and Yeh IT (2007) Basal-like breast cancers. Pathol Case Rev12: 143–153 Article Google Scholar
Seewaldt VL and Scott V (2007) Images in clinical medicine. Rapid progression of basal-type breast cancer. N Engl J Med356: e12 ArticlePubMed Google Scholar
Turner NC and Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene25: 5846–5853 ArticleCASPubMed Google Scholar
Tischkowitz MD and Foulkes WD (2006) The basal phenotype of BRCA1-related breast cancer: past, present and future. Cell Cycle5: 963–967 ArticleCASPubMed Google Scholar
Tsuda H et al. (1999) Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Hum Pathol10: 1134–1139 Article Google Scholar
Tsuda H et al. (2000) Large, central acellular zones indicating myoepithelial tumor differentiaton in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol24: 197–202 ArticleCASPubMed Google Scholar
Albiges L et al. (2005) Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol16: 1846–1847 ArticleCASPubMed Google Scholar
Diallo-Danebrock R et al. (2007) Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy. Clin Cancer Res13: 488–497 ArticleCASPubMed Google Scholar
Harris LN et al. (2007) Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res13: 1198–1207 ArticleCASPubMed Google Scholar
Finn RS et al. (2007) Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat105: 319–326 ArticleCASPubMed Google Scholar
Moyano JV et al. (2006) AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest116: 261–270 ArticleCASPubMedPubMed Central Google Scholar
Flanagan M et al. (2007) EGFR gene amplification is an uncommon event in basal-like breast carcinomas [abstract]. Lab Invest87 (Suppl 1): 31A Google Scholar
Malzahn K et al. (1998) Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch433: 119–129 ArticleCASPubMed Google Scholar
Bertucci F et al. (2006) Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res66: 4636–4344 ArticleCASPubMed Google Scholar
Rodriguez-Pinilla SM et al. (2007) Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study. Am J Surg Pathol31: 501–508 ArticlePubMed Google Scholar
Vincent-Salomon A et al. (2007) Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res9: R24 ArticleCASPubMedPubMed Central Google Scholar
Koenig C et al. (2000) Carcinoma arising in microglandular adenosis: an immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol8: 303–315 ArticlePubMed Google Scholar
Finak G et al. (2006) Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res8: R58 ArticleCASPubMedPubMed Central Google Scholar
Sun Y et al. (2007) Improved breast cancer prognosis through the combination of clinical and genetic markers. Bioinformatics23: 30–37 ArticleCASPubMed Google Scholar